Latest Regulatory News

Peninsula Energy reports progress on its Lance Project’s Central Processing Plant and announces the termination of three sales contracts as part of a strategic reset plan, while engaging in funding discussions to support completion.

The Calmer Co. has secured a major retail milestone by launching its Fiji Kava 50g Instant Kava product across Woolworths supermarkets nationwide, significantly broadening its Australian footprint.

ASIC has initiated a comprehensive compliance inquiry into ASX’s governance, risk management, and operational capabilities, folding its previous CHESS incident probe into this broader review. ASX pledges full cooperation amid ongoing technology upgrades.

Zenith Minerals Limited has had its trading suspension lifted immediately following the release of a rights issue announcement, signaling a key capital raising move.

Zenith Minerals has launched a fully underwritten $3.5 million entitlement offer to fund drilling at its key gold projects in Western Australia and Queensland, aiming to expand mineral resources and advance exploration.

PointsBet Holdings has formalised a conditional takeover bid deed with MIXI at $1.20 per share, activating if shareholders reject the current scheme of arrangement. The deal hinges on key regulatory approvals and a minimum 50.1% acceptance threshold.

Artrya Limited has submitted a pivotal FDA 510(k) application for its AI-powered Salix® Coronary Plaque module, aiming for clearance in Q3 2025 and a lucrative US commercial launch.

Nyrada’s Phase I clinical trial for its novel drug Xolatryp has cleared safety reviews through four cohorts and will now test higher doses and longer infusions in an expanded trial design.

Gibb River Diamonds has successfully completed a heritage survey over the proposed open pit at its Neta Prospect, removing a key obstacle to mining development within the Edjudina Gold Project. The project moves closer to production with mining costs borne by a private contractor.

Santos Limited has received a compelling non-binding proposal from the XRG Consortium to acquire the company at a significant premium, prompting the board to engage in due diligence and negotiations. This move could reshape the Australian energy landscape if finalized.

EVE Health Group’s subsidiary Nextract has inked a pivotal two-year agreement with TeleDocs Clinic, enabling nationwide online prescribing of its upcoming erectile dysfunction and dysmenorrhea products ahead of regulatory approval.

IRIS Metals has reported promising high-grade lithium intersections from its Phase I drilling at the Edison Project in South Dakota, reinforcing its strategy to develop a centralized lithium processing hub in the US.